Sopris Capital completes acquisition of medical imaging firm Blackford Analysis from Bayer

Private equity firm Sopris Capital has completed the acquisition of medical artificial intelligence company Blackford Analysis from Bayer. PE Hub, PR Newswire Business, and AuntMinnie all reported that the Miami-based investment firm finished the carve-out transaction on October 9, 2026. [1][2][3]

PE Hub reported that Edinburgh-based Blackford operates an AI orchestration platform designed for radiology departments. PE Hub added that the platform provides healthcare facilities with direct access to more than 130 imaging applications created by over 45 different vendors. [1]

According to PR Newswire Business, Sopris Capital is a multi-strategy investment firm focused on building a portfolio of healthcare technology companies. The outlet noted that the acquisition expands Sopris Capital's existing platform and supports its commitment to providing end-to-end patient care. [2]

Artificial intelligence allows computational systems to execute tasks usually associated with human intelligence, including learning, reasoning, and decision-making. Neither Sopris Capital nor Bayer disclosed the financial terms or transaction value of the acquisition. [1][2][3][5]